These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome. Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119 [TBL] [Abstract][Full Text] [Related]
3. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2. Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538 [TBL] [Abstract][Full Text] [Related]
4. Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome. Kamakura T; Wada M; Ishibashi K; Inoue YY; Miyamoto K; Okamura H; Nagase S; Noda T; Aiba T; Yasuda S; Kusano K Heart Vessels; 2017 Oct; 32(10):1277-1283. PubMed ID: 28523371 [TBL] [Abstract][Full Text] [Related]
5. Impact of pacing and high-pass filter settings on ventricular bipolar electrograms in implantable cardioverter defibrillator systems. - Implication of predictors for inappropriate therapy caused by oversensing of repolarization electrograms-. Maesato A; Higa S; Lin YJ; Chinen I; Ishigaki S; Yajima M; Masuzaki H; Chen SA Circ J; 2011; 75(9):2095-104. PubMed ID: 21757820 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome. Kamakura T; Wada M; Nakajima I; Ishibashi K; Miyamoto K; Okamura H; Noda T; Aiba T; Takaki H; Yasuda S; Ogawa H; Shimizu W; Makiyama T; Kimura T; Kamakura S; Kusano K Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):785-91. PubMed ID: 26067668 [TBL] [Abstract][Full Text] [Related]
7. Long-term prognosis in patients with Brugada syndrome based on Class II indication for implantable cardioverter-defibrillator in the HRS/EHRA/APHRS Expert Consensus Statement: multicenter study in Japan. Takagi M; Sekiguchi Y; Yokoyama Y; Aihara N; Hiraoka M; Aonuma K; Heart Rhythm; 2014 Oct; 11(10):1716-20. PubMed ID: 24981871 [TBL] [Abstract][Full Text] [Related]
8. Makarawate P; Chaosuwannakit N; Vannaprasaht S; Sahasthas D; Koo SH; Lee EJD; Tassaneeyakul W; Barajas-Martinez H; Hu D; Sawanyawisuth K J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28584071 [TBL] [Abstract][Full Text] [Related]
9. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Sacher F; Probst V; Iesaka Y; Jacon P; Laborderie J; Mizon-Gérard F; Mabo P; Reuter S; Lamaison D; Takahashi Y; O'Neill MD; Garrigue S; Pierre B; Jaïs P; Pasquié JL; Hocini M; Salvador-Mazenq M; Nogami A; Amiel A; Defaye P; Bordachar P; Boveda S; Maury P; Klug D; Babuty D; Haïssaguerre M; Mansourati J; Clémenty J; Le Marec H Circulation; 2006 Nov; 114(22):2317-24. PubMed ID: 17116772 [TBL] [Abstract][Full Text] [Related]
10. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Spencker S; Coban N; Koch L; Schirdewan A; Müller D Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654 [TBL] [Abstract][Full Text] [Related]
11. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience. Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005 [TBL] [Abstract][Full Text] [Related]
12. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B; Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142 [TBL] [Abstract][Full Text] [Related]
13. T wave oversensing by a cardioverter defibrillator implanted in a patient with the Brugada syndrome. Porres JM; Brugada J; Marco P; García F; Azcarate B Pacing Clin Electrophysiol; 2004 Nov; 27(11):1563-5. PubMed ID: 15546314 [TBL] [Abstract][Full Text] [Related]
14. Noise, artifact, and oversensing related inappropriate ICD shock evaluation: ALTITUDE noise study. Powell BD; Asirvatham SJ; Perschbacher DL; Jones PW; Cha YM; Cesario DA; Cao M; Gilliam FR; Saxon LA Pacing Clin Electrophysiol; 2012 Jul; 35(7):863-9. PubMed ID: 22519674 [TBL] [Abstract][Full Text] [Related]
15. Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study. Conte G; Cattaneo F; de Asmundis C; Berne P; Vicentini A; Namdar M; Scalone A; Klersy C; Caputo ML; Demarchi A; Özkartal T; Salghetti F; Casu G; Passarelli I; Mameli S; Shah D; Burri H; De Ferrari G; Brugada P; Auricchio A Europace; 2022 May; 24(5):845-854. PubMed ID: 34499723 [TBL] [Abstract][Full Text] [Related]